Bio-Rad Laboratories, Inc.
BIO
$265.26
$0.940.36%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 114.68% | -83.33% | -304.67% | 514.71% | -86.32% |
| Total Depreciation and Amortization | 11.54% | 2.70% | 5.38% | 4.29% | 1.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.98% | 96.10% | 441.52% | -1,628.60% | 80.92% |
| Change in Net Operating Assets | 111.35% | -19.26% | -2,534.15% | 8,928.00% | -77.97% |
| Cash from Operations | 19.36% | 86.10% | 53.33% | 67.39% | -0.48% |
| Capital Expenditure | -8.04% | 14.43% | -1.54% | 8.72% | -22.12% |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -151.04% | -12.31% | 156.41% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,200.00% | 1,386.21% | -88.90% | -144.82% | -81.94% |
| Cash from Investing | -273.46% | 106.73% | -142.31% | -485.64% | -210.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | 50.00% | 72.85% | -4.24% | 13.79% |
| Issuance of Common Stock | -10.64% | -21.82% | -9.74% | 9.79% | -7.79% |
| Repurchase of Common Stock | -38.64% | -2,068.09% | 99.93% | -224.36% | 51.28% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.10% | -- | 86.91% | -260.88% | 52.35% |
| Foreign Exchange rate Adjustments | -526.32% | -166.67% | 257.46% | -220.80% | 42.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1,300.00% | 1,300.00% | -- |
| Net Change in Cash | -480.08% | 13.27% | 244.01% | -93.41% | 64.74% |